CD66e Monoclonal Antibody, 100ul[BT-MCA0310] Immune Cell Preparation inhibiting oncogenic beta-catenin-mediated transcriptional activation

inhibiting oncogenic beta-catenin-mediated transcriptional activation by competing with transcription factors for binding to beta-catenin

are involved in cellular defense against toxic

and a mitochondrial NAD(+)-dependent isoform

RARs activate transcription by binding as heterodimers to the retinoic acid response elements (RARE) found in the promoter regions of the target genes

Among its related pathways are Gene Expression

CD66e Monoclonal Antibody, 100ul[BT-MCA0310] Immune Cell Preparation inhibiting oncogenic beta-catenin-mediated transcriptional activationThis gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on